Press release
SGD Pharma advances sustainable manufacturing and supply chain innovation at DCAT Week 2025 in New York
Paris La Défense, FRANCE - 19th March 2025: SGD Pharma, a global market leader in pharmaceutical glass primary packaging solutions, leads the charge towards greater sustainability and innovation by highlighting its multi-million investments into the next-generation of glass manufacturing and commitment to strengthening pharma supply chains in the US and beyond. DCAT Week takes place between 17th-20th March 2025 and is one of the most influential gatherings for pharmaceutical and biotech companies from across the world, providing a powerful platform for high-level discussions, networking and collaboration with key industry leaders.SGD Pharma has committed multi-million-euro investment in recent years to modernize its global manufacturing sites, strengthen its high-precision vial production to meet growing pharma demand and upgrade its furnaces to reduce carbon emissions and energy use. SGD Pharma has been recognized by EcoVadis with a platinum medal for 2024 - placing it in the top 1% of the glass industry (and all companies evaluated) and the company's decarbonization targets have been validated by the Science Based Targets initiative (SBTi), marking an important milestone in the company's decarbonization journey.
Fabio Invernizzi, General Manager BU West and Carole Grassi Mircich, Chief Commercial Marketing & Innovation Officer will be attending to support SGD Pharma's US team in strategic discussions. Carole adds "I am excited to attend DCAT Week and reconnect with our valued customers and partners. We are eager to dive deep into understanding their evolving needs, showcase our cutting-edge innovations, and explore new opportunities for collaboration that will drive the future of our industry."
SGD Pharma continues to drive innovation in pharmaceutical packaging with significant investments and advancements. As proof of our commitment to continuing investment into the quality of our products, SGD Pharma opened a new siliconization operation at its Saint-Quentin Lamotte (SQLM) plant to provide customers with Sealian glass treatment which provides a protective barrier for sensitive, aggressive, and viscous drug products across all administration routes. Additionally, its IDENCY Type I glass vials offer increased chemical durability for parenteral drugs while maintaining compatibility with standard fill & finish processes for improved efficiency. To accelerate market delivery, SGD Pharma has expanded its Sterinity EZ-fill®* ready-to-use (RTU) vial offerings, reducing operational complexities and costs for pharma companies. Further optimizing production, Velocity® Vials-developed with Corning-feature a friction-reducing outer coating, improving manufacturing efficiency by up to 50% and minimizing disruptions. Through these advancements, SGD Pharma reinforces its commitment to innovation, ensuring high-quality, efficient, and reliable packaging solutions for the evolving pharmaceutical industry.
With increasing regulatory demands and growing expectations for eco-conscious production, SGD Pharma is committed to delivering pharmaceutical glass packaging solutions that enhance drug safety and efficiency while setting industry benchmarks in sustainability. At DCAT week, the team will engage with existing partners, customers and industry stakeholders as well as forge new partnerships to explore how the company can continue to create meaningful, impactful solutions to address the most pressing challenges faced by the pharmaceutical industry. Contact SGD Pharma to set up a meeting.
*EZ-fill® is a registered trademark of Stevanato Group and/or its affiliates in one or more jurisdictions.
ENDS
Liberty Tower 17 place des Reflets CS 30300 92097 Paris La Défense Cedex
Tel : +33 (0)1 4090 3600
Marketing & Communication SGD Pharma:
communication@sgdgroup.com
About SGD Pharma:
SGD Pharma is a global producer of molded and tubular glass for pharmaceutical primary packaging. Building on over a century of expertise, we provide exceptional quality packaging solutions dedicated to parenteral, oral, and nasal products for every therapeutic application. Our worldwide clients are supported by more than 90 agents and distributors and benefit from ongoing innovation at our five best-in-class ISO 15378 certified, GMP compliant manufacturing plants, giving a truly global supply chain infrastructure.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release SGD Pharma advances sustainable manufacturing and supply chain innovation at DCAT Week 2025 in New York here
News-ID: 3932812 • Views: …
More Releases from The Scott Partnership
Linkam showcases new stage innovation at M&M 2025
Market leader in temperature and environmental-controlled microscopy, Linkam Scientific Instruments, will be presenting a range of stages at this year's Microscopy & Microanalysis (M&M) 2025. The showcase will include its cryo portfolio, amongst other new developments, at booth #1439, M&M Salt Lake City, July 27-31.
15 July 2025: Linkam Scientific Instruments is showcasing a range of microscopy stages and instrumentation at this year's M&M conference, including its core stages, new products,…
N4 Pharma announces collaboration with SRI to target and treat cells in the huma …
April 25th, 2024: N4 Pharma Plc (AIM: N4P), the specialist pharmaceutical company developing Nuvec®, a novel delivery system designed to carry nucleotides to be developed as cancer treatments and vaccines, has entered into a research collaboration agreement with SRI, an independent nonprofit research institute based in Silicon Valley, California, to combine Nuvec with SRI's proprietary FOX Three Molecular Guidance System™ (MGS) with the aim of co-marketing the combined technology. The…
N4 Pharma's novel delivery systems, Nuvec® and LipTide®, advance towards comme …
27th February 2024: N4 Pharma PLC (AIM: N4P), the pre-clinical stage specialist pharmaceutical company, recently acquired a controlling interest in Nanogenics Limited. Nanogenics has developed a lipid and peptide-based delivery system, LipTide®, which it is using in the formulation of a novel siRNA product - ECP105 - targeting an unmet clinical need in the ophthalmology market.
Alongside its ongoing pre-clinical research into Nuvec® - N4 Pharma's unique novel silica nanoparticle…

Bruker Introduces New Mycobacteria and Fungi IVD Solutions for MALDI Biotyper®, …
BILLERICA, MA, April 14, 2023 - At the 33rd European Congress of Clinical Microbiology & Infectious Diseases, Bruker Corporation (Nasdaq: BRKR) announces its latest innovations for user-friendly, best-in-class diagnostic solutions for routine clinical microbiology and infection diagnostics laboratories.
• MBT Mycobacteria IVD Kit optimizes sample preparation and comprehensive library of MBT HT Mycobacteria IVD Module
• MBT HT Filamentous Fungi IVD Module incorporates extensive fungal library with easy and effective sample preparation (MyT)…
More Releases for SGD
Ampoules Packaging Market Is Booming Worldwide with Gerresheimer, Schott, SGD Ph …
HTF MI just released the Global Ampoules Packaging Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach.
Major companies profiled in Ampoules Packaging Market are:
Gerresheimer, Schott, SGD…
SGD Pharma showcases its SEALIAN platform at Pharmapack Europe 2025
Paris La Défense, FRANCE - 20th January 2025: SGD Pharma, a global market leader in pharmaceutical glass primary packaging solutions, will present its innovative range of products and services, including its platform Sealian, an internal treatment that enhances the performance of molded glass vials, on its booth B55 & B59 at Pharmapack. Held in Paris, France, Pharmapack is the leading European trade show for pharmaceutical packaging taking place between…
Speech Generating Devices SGD Market Size 2024 to 2031.
Market Overview and Report Coverage
A Speech Generating Device (SGD) is a type of assistive technology that helps individuals with speech impairments communicate more effectively. These devices often use text-to-speech technology or pre-recorded messages to help users express themselves.
The Speech Generating Devices SGD market is expected to experience steady growth in the coming years. The market is expected to grow at a CAGR of 4.90% during the forecasted period.…
Pharmaceutical Glass Packaging Market 2022 Growth Outlook - Gerresheimer Glass I …
The Pharmaceutical Glass Packaging Market report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The global pharmaceutical glass…
Global Speech Generating Devices (SGD) Market Insights, Forecast
The Speech Generating Devices (SGD) market was valued at Million US$ in 2017 and is projected to reach Million US$ by 2025, at a CAGR of during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Speech Generating Devices (SGD)
Get sample copy of the report:
https://www.marketdensity.com/contact?ref=Sample&reportid=54663
Table of Contents:
Table of Contents
1 Study Coverage
…
GLOBAL PHARMACEUTICALS PACKAGING MARKET- NIPRO, NGPACK, SVAM PACKAGING, SCHOTT, …
Global Market Study Evaluate on Pharmaceuticals Packaging Industry by Type, Manufacturers, Application, Type, and Regions, Forecast up to 2022
The scope of the global Pharmaceuticals Packaging market report is:
This report offers a comprehensive evaluation of the Pharmaceuticals Packaging market. It does so by in-depth qualitative insights, historical Pharmaceuticals Packaging market data, and verifiable projections about global Pharmaceuticals Packaging market size. The projections featured in the Pharmaceuticals Packaging market report have been…